• Investors may be wondering whether Quaker Chemical at around US$137.99 is still offering value, or if most of the easy gains are already behind it.
• The stock is down about 6.5% over the last week and 1.3% over the last month, roughly flat year to date with a 0.7% decline, yet still up 31.1% over the past year after longer term declines of 31.4% over three years and 37.0% over five years.
• Recent coverage has focused on Quaker Chemical's position in the specialty chemicals sector and how investors are reassessing companies with longer term share price declines alongside more recent recoveries. This shift in attention helps explain why a stock with mixed multi year returns can still attract interest after a stronger 12 month period.
• Quaker Chemical currently holds a 2/6 valuation score. This raises the question of how different valuation methods, and an even richer way of thinking about value discussed at the end of this article, might change how you see the stock.

Quaker Chemical scores just 2/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.

Approach 1: Quaker Chemical Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model estimates what a stock could be worth today by projecting the company’s future cash flows and then discounting those back into today’s dollars.

For Quaker Chemical, the model used is a 2 Stage Free Cash Flow to Equity approach based on cash flow projections. The company’s latest twelve month free cash flow is about $95.34 million, and analyst inputs plus extrapolated estimates point to free cash flow of $128.00 million in 2028, with a full set of annual projections out to 2035 provided by Simply Wall St.

When those projected cash flows are discounted back and summed, the DCF model arrives at an estimated intrinsic value of about $107.77 per share. Compared with the recent share price around $137.99, the model suggests the stock is trading at a premium, with an implied overvaluation of roughly 28.0%.

Result: OVERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Quaker Chemical may be overvalued by 28.0%. Discover 51 high quality undervalued stocks or create your own screener to find better value opportunities.

Approach 2: Quaker Chemical Price vs Sales

For profitable companies where revenue is a meaningful driver of earnings power, the P/S ratio can be a useful way to think about what you are paying for each dollar of sales. Higher growth expectations or lower perceived risk can justify a higher “normal” P/S multiple, while slower growth or higher risk usually points to a lower one.

Quaker Chemical currently trades on a P/S ratio of 1.24x. This sits slightly above the Chemicals industry average of about 1.12x and close to the peer average of 1.12x, so on simple comparisons the stock is not far from the broader group. Simply Wall St’s Fair Ratio for Quaker Chemical is 1.53x, which is a proprietary estimate of what the P/S might be given factors such as the company’s earnings growth profile, profit margins, industry, market cap and risk characteristics.

This Fair Ratio is more tailored than a basic peer or industry comparison because it aims to adjust for differences in growth, risks and profitability rather than assuming all companies should trade at the same multiple. Since Quaker Chemical’s current 1.24x P/S sits below the 1.53x Fair Ratio, the stock appears undervalued on this metric.

Result: UNDERVALUED

P/S ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 19 top founder-led companies.

Upgrade Your Decision Making: Choose your Quaker Chemical Narrative

Earlier it was mentioned that there is an even better way to understand valuation, so Narratives step in as a simple framework where you spell out your story for Quaker Chemical, link it to explicit assumptions for future revenue, earnings and margins, and let the Simply Wall St platform turn that into a Fair Value you can compare with the current price on the Community page.

Each Narrative connects the company story to a forecast and then to a Fair Value that updates when fresh information like earnings or news arrives. This allows you to judge for yourself whether the current US$137.99 price looks high or low against your numbers and to decide whether that points to buying, holding or selling.

For example, one Quaker Chemical Narrative with a Fair Value of US$180 might assume earnings of US$223.9m by 2029 at a P/E of 16.5x, while a more cautious Narrative using US$151 reflects a lower fair value. Seeing those side by side helps you decide which story, and which set of assumptions, best matches your own view.

Do you think there's more to the story for Quaker Chemical? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.